Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-035783
Filing Date
2012-06-11
Accepted
2012-06-11 16:08:19
Documents
1
Period of Report
2012-06-08

Document Format Files

Seq Description Document Type Size
1 FORM4-STOCKPURCHASE rrd348424.html 4  
1 FORM4-STOCKPURCHASE rrd348424.xml 4 3549
  Complete submission text file 0001181431-12-035783.txt   5172
Mailing Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615
Business Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615 919-861-0202
DARA BioSciences, Inc. (Issuer) CIK: 0000919745 (see all company filings)

EIN.: 043216862 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615
Business Address
Drutz David (Reporting) CIK: 0001428764 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23776 | Film No.: 12900575